Porton Pharma
Porton Pharma Solutions Ltd., commonly referred to as Porton Pharma, is a leading contract development and manufacturing organisation (CDMO) headquartered in China (CN). Established in 2003, the company has rapidly expanded its operational footprint across major regions, including North America and Europe, positioning itself as a key player in the pharmaceutical and biotechnology sectors. Specialising in the development and production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, Porton Pharma is renowned for its commitment to innovation and regulatory compliance. The company’s state-of-the-art facilities and advanced technologies enable it to deliver tailored solutions that meet the stringent demands of its global clientele. With a strong market presence and a reputation for excellence, Porton Pharma has achieved significant milestones, including successful partnerships with leading pharmaceutical companies and a robust portfolio of proprietary products.
DitchCarbon Score
How does Porton Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Porton Pharma's score of 10 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Porton Pharma's reported carbon emissions
Porton Pharma, headquartered in China (CN), currently does not provide specific carbon emissions data or reduction targets. Without available figures on their emissions, it is challenging to assess their climate impact or commitments. However, the company may be engaged in various initiatives to address climate change, as is common in the pharmaceutical industry. Many companies in this sector are increasingly focusing on sustainability and setting ambitious targets to reduce their carbon footprint. For a comprehensive understanding of Porton Pharma's climate commitments, further information would be required.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Porton Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
